- Home
- WRLD vs NBTX Comparison
WRLD vs NBTX Comparison
Compare WRLD & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRLD
- NBTX
- Stock Information
- Founded
- WRLD 1962
- NBTX 2003
- Country
- WRLD United States
- NBTX France
- Employees
- WRLD N/A
- NBTX N/A
- Industry
- WRLD Finance: Consumer Services
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- WRLD Finance
- NBTX Health Care
- Exchange
- WRLD Nasdaq
- NBTX Nasdaq
- Market Cap
- WRLD 859.5M
- NBTX 868.8M
- IPO Year
- WRLD 1991
- NBTX 2020
- Fundamental
- Price
- WRLD $175.30
- NBTX $21.04
- Analyst Decision
- WRLD
- NBTX Strong Buy
- Analyst Count
- WRLD 0
- NBTX 1
- Target Price
- WRLD N/A
- NBTX $8.00
- AVG Volume (30 Days)
- WRLD 44.4K
- NBTX 112.7K
- Earning Date
- WRLD 10-24-2025
- NBTX 09-30-2025
- Dividend Yield
- WRLD N/A
- NBTX N/A
- EPS Growth
- WRLD 10.95
- NBTX N/A
- EPS
- WRLD 14.92
- NBTX N/A
- Revenue
- WRLD $567,706,032.00
- NBTX $11,930,711.00
- Revenue This Year
- WRLD N/A
- NBTX N/A
- Revenue Next Year
- WRLD $3.55
- NBTX $74.67
- P/E Ratio
- WRLD $11.95
- NBTX N/A
- Revenue Growth
- WRLD 0.80
- NBTX N/A
- 52 Week Low
- WRLD $104.99
- NBTX $2.76
- 52 Week High
- WRLD $185.48
- NBTX $22.51
- Technical
- Relative Strength Index (RSI)
- WRLD 53.78
- NBTX 71.69
- Support Level
- WRLD $165.96
- NBTX $19.11
- Resistance Level
- WRLD $179.60
- NBTX $22.64
- Average True Range (ATR)
- WRLD 5.42
- NBTX 1.64
- MACD
- WRLD -0.12
- NBTX 0.63
- Stochastic Oscillator
- WRLD 47.86
- NBTX 83.03
About WRLD World Acceptance Corporation
World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals. The Company operates 1,024 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.